- Home
- CRNC vs FENC Comparison
CRNC vs FENC Comparison
Compare CRNC & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CRNC | FENC |
|---|---|---|
| Founded | 2020 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 316.0M | 266.4M |
| IPO Year | 2019 | 2010 |
Fundamental Metrics
Financial Performance| Metric | CRNC | FENC |
|---|---|---|
| Price | $6.03 | $5.95 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 3 |
| Target Price | $11.50 | ★ $15.00 |
| AVG Volume (30 Days) | ★ 567.6K | 186.4K |
| Earning Date | 05-06-2026 | 03-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 96.95 | 96.67 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $251,781,000.00 | $47,538,000.00 |
| Revenue This Year | $27.17 | $75.81 |
| Revenue Next Year | N/A | $25.06 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 123.69 |
| 52 Week Low | $5.94 | $4.68 |
| 52 Week High | $13.74 | $9.92 |
Technical Indicators
Market Signals| Indicator | CRNC | FENC |
|---|---|---|
| Relative Strength Index (RSI) | 23.57 | 31.07 |
| Support Level | N/A | N/A |
| Resistance Level | $7.42 | $8.27 |
| Average True Range (ATR) | 0.32 | 0.49 |
| MACD | 0.00 | -0.19 |
| Stochastic Oscillator | 0.00 | 2.21 |
Price Performance
Historical ComparisonAbout CRNC Cerence Inc.
Cerence Inc is a United States-based software company. It is involved in developing mobility-based solutions for drivers and their cars. The customers include all automobile original equipment manufacturers, or OEMs, or their tier 1 suppliers. The company's revenue is generated by selling software licenses and cloud-connected services. Geographically, it derives a majority of its revenue from the United States and also has a presence in Other Americas; Germany; Other Europe, the Middle East, Africa; Japan, and Other Asia-Pacific.
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.